016580 — Whanin Pharm Co Balance Sheet
0.000.00%
- KR₩225bn
- KR₩153bn
- KR₩230bn
- 81
- 84
- 44
- 85
Annual balance sheet for Whanin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 111,791 | 116,956 | 146,043 | 87,292 | 78,066 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 64,555 | 64,106 | 63,120 | 72,326 | 78,947 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 204,977 | 214,355 | 242,412 | 197,422 | 212,101 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 39,697 | 45,822 | 46,869 | 109,854 | 131,211 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 304,885 | 329,560 | 353,189 | 369,375 | 401,227 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 24,743 | 26,725 | 30,900 | 31,750 | 40,028 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 31,108 | 33,445 | 36,249 | 35,863 | 43,019 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 273,777 | 296,115 | 316,939 | 333,511 | 358,207 |
Total Liabilities & Shareholders' Equity | 304,885 | 329,560 | 353,189 | 369,375 | 401,227 |
Total Common Shares Outstanding |